Rhabdoid Tumors Cellular Architecture by Single-cell Analyses (InnovRT-2)

Plain-language summary

This study examines the cellular architecture of rhabdoid tumors in children using single-cell analyses. Children aged 0-17 who have, or likely have, a rhabdoid tumor based on clinical and radiological features and who undergo surgery as part of standard care could take part. It was a study without a phase designation and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Assistance Publique - Hôpitaux de Paris

Intervention

analyzes in singles cells

Start date

3/31/2022

Estimated completion

2/21/2025

Countries

France

Related genes

Locations

• Paris, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Aged 0-17 years old
* having a rhabdoid tumor according to clinical and radiological features Or likely having a rhabdoid tumor according to clinical and radiological features
* surgical resection in standard care
* sufficient material for both diagnosis and experimental procedures
* parents' agreement